Home > Drug Search >
  • company_query: Angiogene Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (17) biology (3)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (8) Phase Ⅰ (8)
Clinical Stage:
Pending (4) Active (9) Discontinued (6)
Indication:
Alzheimer's disease (AD) (1) Anxiety (1) Asthma (1) Breast cancer (2) Rectal cancer (1) Cognitive disorders (1) Depression (1) Diabetic macular edema (1) Eye disorders (1) HCV infection (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Inflammatory bowel disease (1) Lung cancer (1) Major depressive disorder (MDD) (1) Malignancies (1) Melanoma (1) Multiple sclerosis (MS) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (3) Pancreatic cancer (1) Peptic ulcer (1) Rheumatoid arthritis (RA) (1) Smoking cessation (1) Solid tumours (2) Type 2 diabetes (1) Colorectal cancer (1) Colon cancer (1) Age-related macular degeneration (AMD) (1) Anaplastic astrocytoma (1) Glioblastoma (2) Hepatic fibrosis (1) Allergic asthma (1) Cocaine abuse (1) Liver cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top